Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
In two decades at UW, Dr. Hartzler’s principal focus has been on the dissemination and implementation of empirically-supported health services for persons with substance use disorders. To date, this includes local, regional, national, and international collaborations, encompassing federally-funded work with diverse community-based settings (i.e., addiction care, mental health, primary and specialty medical care, criminal justice, HIV care, schools, faith-based organizations), including those affiliated with the NIDA Clinical Trials Network. As director of the UW Center for Advancing Addiction Health Services (CAAHS), he oversees a broad portfolio, including: 1) the SAMHSA-funded Northwest Addiction Technology Transfer Center (Northwest ATTC), which provides universal, targeted, and intensive technical assistance to the addiction workforce in Alaska, Idaho, Oregon, and Washington 2) regional contribution to SAMHSA’s national Opioid Response Network (ORN), 3) a host of externally-sponsored implementation projects with single-state authorities as well as other organizations, and 4) contribution to NIH-funded and intramural health services research. In professional endeavors that span a science-to-service continuum, Dr. Hartzler seeks to promote adoption and implementation of useful treatment and recovery practices in community settings where they may benefit persons with substance use disorders.
Dr. Banta-Green studies substance use involving opioids and stimulants and interventions to support recovery and reduce substance-related harms. He is particularly interested in developing interventions that are accessible to all people, including those who are most marginalized, such as those who are unhoused, utilizing services syringe service programs, and/or in the criminal legal system. He provides technical assistance and evaluation services for public health and safety interventions including the website http://stopoverdose.org, and information for the general public and professionals about effective treatments at http://learnabouttreatment.org. As an epidemiologist he develops innovative approaches to measuring the use and impacts of substances as well as service utilization. His health services research involves clinical trials, implementation research, and secondary data analyses. He serves on local, state, and federal workgroups and committees related to epidemiology, policy, and interventions for illicit substance-related problems. He is a member of the U.S. Health and Human Service’s Interdepartmental Substance Use Disorders Coordinating Committee.
My primary areas of research include artificial intelligence, AI/machine ethics, behavioral health technologies, telemedicine, telehealth, forensic psychology, and military and Veteran population health. I’ve consulted widely on the topic of military and veteran health and technology in healthcare and have helped to develop national guidelines for telemental health, clinical best practices for technology-based treatments, and standards for human-AI interaction transparency. My vision is to build, and help others to build, technologies that help promote behavioral change and that improve the lives of people.
Jill Locke, Ph.D., is an Associate Professor in the UW Department of Psychiatry and Behavioral Sciences, a licensed child psychologist and the former co-Director of the SMART Center from 2020-23. To date, her research has focused on the: 1) presentation of social impairment for autistic youth; 2) identification of best practices for autistic youth; and 3) understanding of successful implementation and sustainment of evidence-based practices (EBPs) for autistic youth in public school settings. Her current research focuses on understanding EBP use to support autistic youth in inclusive settings and developing and testing implementation strategies to support the adoption, implementation, and sustainment of EBPs in public schools.
I completed my adult psychiatry residency at the University of California, Davis and went on to complete my child & adolescent psychiatry fellowship at Seattle Children’s. My clinical work is focused on inpatient psychiatry and psychopharmacology. I have a particular interest in working with families and children in management of disruptive behavior disorders.
I am a Psychologist and the Coordinator of the DBT Program at the VA Puget Sound Health Care System as well as an Associate Professor in the Department of Psychiatry and Behavioral Sciences and Adjunct Associate Professor in the Department of Psychology at the University of Washington. I previously worked as the Research Director of Dr. Marsha Linehan’s Behavioral Research and Therapy Clinics at the University of Washington (2006-2018), Director of Research and Development for Behavioral Tech, LLC (2014-2017), and Director of Behavioral Tech Research, Inc. (2013-2016). My research focuses on the development and evaluation of the DBT Prolonged Exposure protocol for PTSD as well as methods of disseminating and implementing this and other evidence-based treatments into clinical practice. I regularly provide training and consultation nationally and internationally in DBT and DBT PE and have published numerous articles and book chapters on these treatments. I am a certified DBT therapist, a certified PE therapist and supervisor, am board certified in Behavioral and Cognitive therapy, and am licensed as a psychologist in the state of Washington.
I am a child and adolescent psychiatrist at Seattle Children’s Hospital and faculty member at the University of Washington Medicine. My SCH practice locations include the Gender Clinic (Adolescent Medicine), Outpatient Psychiatry Clinic, Autism Center, and the inpatient unit- Psychiatry and Behavioral Medicine Unit (PBMU). I believe in delivering compassionate, evidence-based care in supporting patients and their families. My approach is both comprehensive and patient-centered, as it is important to consider the needs of the individual while also appreciating societal and cultural context. I specialize in working with diverse patient populations with various marginalized identities, such as those who identify as LGBTQ, gender diverse, and/or neurodiverse. I also work closely with the Adolescent Medicine Gender Clinic in supporting any mental health needs of transgender/gender diverse youth and their families. I also collaborate with colleagues in specialty medical clinics to coordinate care of medically complex patients. Additionally, I serve as a consultant with various school programs to support mental health initiatives and advocacy efforts.
Academically, I am involved with several initiatives both locally and nationally, particularly those that work to promote diversity and equity. I serve on committees supporting the SCH/UW CAP Fellowship Program, educating trainees and students through direct clinical supervision as well as with lectures and discussions. On a national level, I serve on the Sexual Orientation and Gender Identity Issues Committee (SOGIIC) for the American Academy of Child and Adolescent Psychiatry (AACAP). My clinical research focuses on finding strategies to better support the mental health and well-being of patients and families who are LGBTQ+. Additionally, I work on studies that explore the intersection between gender diversity and neuro diversity/autism spectrum.
